Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Iron Deficiency Is Associated With Impaired Myocardial Reperfusion in ST-Segment-Elevation Myocardial Infarction, Influence of the Definition Used

  • Barrabés, José A.|||0000-0001-7062-6277
  • Inserte, Javier|||0000-0003-2283-3591
  • Castellote, Laura
  • Buera Surribas, Irene|||0000-0001-6110-2367
  • Milà Pascual, Laia|||0009-0007-4932-657X
  • Sambola, Antonia
  • Uribarri, Aitor|||0000-0002-6911-7480
  • Vidal Burdeus, María|||0000-0002-9823-5021
  • Aluja, David|||0000-0002-0448-9419
  • Delgado-Tomás, Sara
  • Tobías-Castillo, Pablo E.|||0000-0003-0304-6197
  • Calvo-Barceló, Maria
  • Guala, Andrea|||0000-0002-5006-8164
  • Rodríguez Palomares, José F.|||0000-0002-7229-9780
  • García del Blanco, Bruno|||0000-0002-4527-1600
  • Beneitez Pastor, David|||0000-0002-6541-6600
  • Ferreira-Gonzalez, Ignacio|||0000-0002-1208-5561
The role of iron deficiency (ID) in ST-segment-elevation myocardial infarction (STEMI) remains unclear. This study aimed to assess whether ID is associated with impaired myocardial reperfusion in STEMI and whether this association is affected by ID definition. We included 942 consecutive patients with STEMI successfully treated with primary percutaneous coronary intervention. ID was defined either as recommended by international guidelines or, alternatively, as ferritin <100 ng/mL, transferrin saturation <20%, or serum iron ≤13 μmol/L. In 595 patients, serum soluble transferrin receptor levels were measured. Impaired myocardial reperfusion was defined as lack of ST-segment resolution ≥50% 60 to 90 minutes after percutaneous coronary intervention. Results: ID prevalence varied across these definitions. Impaired reperfusion was present in 12.7% of patients without ID and 41.0% of those with ID defined by transferrin saturation <20% (P<0.001). This association was less pronounced for serum iron ≤13 μmol/L, weaker for guideline criteria, and absent for high (≥1.59 mg/L) soluble transferrin receptor levels or low ferritin. Transferrin saturation <20%, but not ferritin-based criteria, was associated with poorer clinical course and left ventricular function and higher in-hospital mortality and remained an independent predictor of impaired reperfusion after adjusting for baseline predictors and anemia. Conclusions: ID defined by transferrin saturation <20% is strongly related to impaired ST resolution and predicts a worse in-hospital outcome in patients with STEMI treated with primary percutaneous coronary intervention. The association of other ID criteria with myocardial reperfusion or with the clinical course is weaker or absent. The potential preventive or therapeutic strategies targeting ID in STEMI warrant further investigation.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Versican accumulation drives Nos2 induction and aortic disease in Marfan syndrome via Akt activation

  • Ruiz-Rodríguez, María Jesús
  • Oller, Jorge
  • Martínez-Martínez, Sara
  • Alarcón-Ruiz, Iván
  • Toral, Marta
  • Sun, Yilin
  • Colmenar, Ángel
  • Méndez-Olivares, María José
  • López-Maderuelo, Dolores
  • Kern, Christine B.
  • Nistal Herrera, Juan Francisco
  • Evangelista, Arturo
  • Teixido-Tura, Gisela
  • Campanero, Miguel R.
  • Redondo, Juan Miguel
The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN) and the Pro CNIC Foundation), the CBMSO is supported by Consejo Superior de Investigaciones Científicas and Universidad Autónoma de Madrid. CBMSO and CNIC are Severo Ochoa Centers of Excellence (grants CEX2021-001154-S and CEX2020-001041-S, respectively) funded by MICIN/AEI/10.13039/501100011033. The project leading to these results has received funding from “La Caixa” Banking Foundation under project codes HR18-00068 (to MRC and JMR); Spanish Ministerio de Ciencia e Innovación grant RTI2018-099246-BI00 (MICIU/AEI/FEDER, UE) to JMR, and grants PID2020-115217RB-100 and PID2021-122388OB-100 to MRC and JMR, respectively, funded by MCIN/AEI/10.13039/501100011033; Instituto de Salud Carlos III (CIBER-CV CB16/11/00264 and CB16/11/00479; and grants PI17/00381 to GT-T and PI21/00084 (co-funded by Fondo Europeo de Desarrollo Regional (FEDER)) to JFN); Fundacio La Marato TV3 (20151330 to JMR); Instituto de Investigación Sanitaria Marqués de Valdecilla (IDIVAL) (INNVAL 21/24) to JFN; The Marfan Foundation USA Faculty grant 2017 MRF/1701 (to JMR); Fundación MERCK; Fundación Española de Enfermedades Raras 2022 and V-Ayudas “Muevete por los que no pueden 2021” (to JO); and Spanish Ministerio de Ciencia e Innovación contracts FPI (BES-2016-077649) to MJR-R; Sara Borrell (CD18/00028) and Juan de la Cierva (IJC2020-044581-I) to MT; Ramón y Cajal (RYC2021-033343-I) to JO; and FPU (20/04814) to IA-R.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Efficacy of a cysteine protease inhibitor compared with enalapril in murine heart failure models

  • Aluja, David
  • Delgado Tomás, Sara
  • Ferreira González, Ignacio
  • Barrabés, José A.
  • miro casas, elisabet
  • Ruiz Meana, Marisol
  • Rodriguez-Sinovas, Antonio
  • Benito, Begoña
  • Inserte, Javier
Cardiovascular medicine; Cell biology, Medicina cardiovascular; Biologia cel·lular, Medicina cardiovascular; Biología celular, Cysteine proteases calpains contribute to heart failure (HF), but it remains unknown whether their inhibition provides any benefit compared to standard pharmacological treatment for HF. Here, we characterize the pharmacological properties of NPO-2270 (NPO) as a potent inhibitor of cysteine proteases. Then, we describe that acute administration of NPO in rodent models of transient ischemia at the time of reperfusion reduces myocardial infarction, while its chronic oral administration attenuates adverse remodeling and cardiac dysfunction induced by ischemic and non-ischemic pathological stimuli more effectively than enalapril when given at the same dose. Finally, we provide evidence showing that the effects of NPO correlate with calpain inhibition and the preservation of the T-tubule morphology, due at least in part to reduced cleavage of the calpain substrate junctophilin-2. Together, our data highlight the potential of cysteine protease inhibition with NPO as a therapeutic strategy for the treatment of heart failure., This work was funded by Instituto de Salud Carlos III, Spain, through the projects AES PI20/01681 and AES PI23/00068; and the research network CIBERCV (CB16/11/00479), both cofunded by European Regional Development Fund; Sociedad Española de Cardiología (SEC/FEC-INV-BAS 22/013); Fundació la Marató de TV3 (FLMTV3/202321-30-31) and PERIS STL/484/2023. Long-Sheng Song is supported by the National Institutes of Health of USA.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Implications of Iron Deficiency in STEMI Patients and in a Murine Model of Myocardial Infarction

  • Inserte Igual, Javier
  • Barrabés Riu, José Antonio
  • Aluja Gonzalez, David
  • Bañeras Rius, Jordi
  • Sánchez Sánchez, Ana
  • Mila Pascual, Laia
  • Lidón Corbi, Rosa María
  • De Carvalho Negrao Valente, Filipa Xavier
  • Rafecas Ventosa, Agnès
  • Rodríguez Sinovas, Antonio
  • Benito Villabriga, Begoña
  • Buera Surribas, Irene
  • Ferreira González, Ignacio
  • Beneitez Pastor, David
  • Ruiz Meana, Marisol
  • Miro Casas, Elisabet
  • Rodríguez Palomares, Jose Fernando
  • Sambola Ayala, Antonia
  • Castellote Bellés, Laura
  • Delgado Tomás, Sara
  • Otaegui Irurueta, Imanol
Infarto agudo de miocardio; Sintasa; Deficiencia de hierro, Infart agut de miocardi; Sintasa; Deficiència de ferro, Acute myocardial infarction; Synthase; Iron deficiency, In patients with a first anterior ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention, iron deficiency (ID) was associated with larger infarcts, more extensive microvascular obstruction, and higher frequency of adverse left ventricular remodeling as assessed by cardiac magnetic resonance imaging. In mice, an ID diet reduced the activity of the endothelial nitric oxide synthase/soluble guanylate cyclase/protein kinase G pathway in association with oxidative/nitrosative stress and increased infarct size after transient coronary occlusion. Iron supplementation or administration of an sGC activator before ischemia prevented the effects of the ID diet in mice. Not only iron excess, but also ID, may have deleterious effects in the setting of ischemia and reperfusion., This study was funded by Instituto de Salud Carlos III, Spain, through the project PI16/00232 and the research network CIBERCV (CB16/11/00479), both cofunded by European Regional Development Fund, and by the Sociedad Española de Cardiología (Proyecto de Investigación Traslacional en Cardiología 2016). The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Iron Deficiency Is Associated With Impaired Myocardial Reperfusion in ST‐Segment–Elevation Myocardial Infarction: Influence of the Definition Used

  • Buera Surribas, Irene
  • Mila Pascual, Laia
  • Delgado Tomás, Sara
  • Tobías-Castillo, Pablo Eduardo
  • Barrabés, José A.
  • Inserte, Javier
  • Castellote Bellés, Laura
  • Sambola Ayala, Antonia
  • Uribarri, Aitor
  • Vidal Burdeus, Maria
  • Aluja, David
  • Calvo-Barceló, Maria
  • Guala, Andrea
  • Rodríguez Palomares, José F
  • García del Blanco, Bruno
  • Beneitez Pastor, David
  • Ferreira-Gonzalez, Ignacio
Acute myocardial infarction; Iron deficiency; Reperfusion, Infarto agudo de miocardio; Deficiencia de hierro; Reperfusión, Infart agut de miocardi; Deficiència de ferro; Reperfusió, Background The role of iron deficiency (ID) in ST‐segment–elevation myocardial infarction (STEMI) remains unclear. This study aimed to assess whether ID is associated with impaired myocardial reperfusion in STEMI and whether this association is affected by ID definition. Methods We included 942 consecutive patients with STEMI successfully treated with primary percutaneous coronary intervention. ID was defined either as recommended by international guidelines or, alternatively, as ferritin <100 ng/mL, transferrin saturation <20%, or serum iron ≤13 μmol/L. In 595 patients, serum soluble transferrin receptor levels were measured. Impaired myocardial reperfusion was defined as lack of ST‐segment resolution ≥50% 60 to 90 minutes after percutaneous coronary intervention. Results ID prevalence varied across these definitions. Impaired reperfusion was present in 12.7% of patients without ID and 41.0% of those with ID defined by transferrin saturation <20% (P<0.001). This association was less pronounced for serum iron ≤13 μmol/L, weaker for guideline criteria, and absent for high (≥1.59 mg/L) soluble transferrin receptor levels or low ferritin. Transferrin saturation <20%, but not ferritin‐based criteria, was associated with poorer clinical course and left ventricular function and higher in‐hospital mortality and remained an independent predictor of impaired reperfusion after adjusting for baseline predictors and anemia. Conclusions ID defined by transferrin saturation <20% is strongly related to impaired ST resolution and predicts a worse in‐hospital outcome in patients with STEMI treated with primary percutaneous coronary intervention. The association of other ID criteria with myocardial reperfusion or with the clinical course is weaker or absent. The potential preventive or therapeutic strategies targeting ID in STEMI warrant further investigation., This study was funded by Instituto de Salud Carlos III, Spain, through the projects AES PI16/00232 and AES PI23/00068 and the research network CIBERCV (CB16/11/00479), both co‐funded by European Regional Development Fund, and by the Sociedad Española de Cardiología y Fundación Española del Corazón (SEC/FEC‐INV‐BAS 23/11).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Degradation of GRK2 and AKT is an early and detrimental event in myocardial ischemia/reperfusion

  • Penela, Petronila
  • Inserte, Javier|||0000-0003-2283-3591
  • Ramos, Paula
  • Rodríguez Sinovas, Antonio|||0000-0003-2930-8773
  • García-Dorado, David|||0000-0002-1126-1279
  • Mayor, F.
Background: Identification of signaling pathways altered at early stages after cardiac ischemia/reperfusion (I/R) is crucial to develop timely therapies aimed at reducing I/R injury. The expression of G protein-coupled receptor kinase 2 (GRK2), a key signaling hub, is up-regulated in the long-term in patients and in experimental models of heart failure. However, whether GRK2 levels change at early time points following myocardial I/R and its functional impact during this period remain to be established. Methods: We have investigated the temporal changes of GRK2 expression and their potential relationships with the cardioprotective AKT pathway in isolated rat hearts and porcine preclinical models of I/R. Findings: Contrary to the maladaptive up-regulation of GRK2 reported at later times after myocardial infarction, successive GRK2 phosphorylation at specific sites during ischemia and early reperfusion elicits GRK2 degradation by the proteasome and calpains, respectively, thus keeping GRK2 levels low during early I/R in rat hearts. Concurrently, I/R promotes decay of the prolyl-isomerase Pin1, a positive regulator of AKT stability, and a marked loss of total AKT protein, resulting in an overall decreased activity of this pro-survival pathway. A similar pattern of concomitant down-modulation of GRK2/AKT/Pin1 protein levels in early I/R was observed in pig hearts. Calpain and proteasome inhibition prevents GRK2/Pin1/AKT degradation, restores bulk AKT pathway activity and attenuates myocardial I/R injury in isolated rat hearts. Interpretation: Preventing transient degradation of GRK2 and AKT during early I/R might improve the potential of endogenous cardioprotection mechanisms and of conditioning strategies.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Iron Deficiency Is Associated With Impaired Myocardial Reperfusion in ST‐Segment–Elevation Myocardial Infarction: Influence of the Definition Used

  • Buera Surribas, Irene
  • Mila Pascual, Laia
  • Delgado Tomás, Sara
  • Tobías-Castillo, Pablo Eduardo
  • Barrabés, José A.
  • Inserte, Javier
  • Castellote Bellés, Laura
  • Sambola Ayala, Antonia
  • Uribarri, Aitor
  • Vidal Burdeus, Maria
  • Aluja, David
  • Calvo-Barceló, Maria
  • Guala, Andrea
  • Rodríguez Palomares, José F
  • García del Blanco, Bruno
  • Beneitez Pastor, David
  • Ferreira-Gonzalez, Ignacio
Acute myocardial infarction; Iron deficiency; Reperfusion, Infarto agudo de miocardio; Deficiencia de hierro; Reperfusión, Infart agut de miocardi; Deficiència de ferro; Reperfusió, Background The role of iron deficiency (ID) in ST‐segment–elevation myocardial infarction (STEMI) remains unclear. This study aimed to assess whether ID is associated with impaired myocardial reperfusion in STEMI and whether this association is affected by ID definition. Methods We included 942 consecutive patients with STEMI successfully treated with primary percutaneous coronary intervention. ID was defined either as recommended by international guidelines or, alternatively, as ferritin <100 ng/mL, transferrin saturation <20%, or serum iron ≤13 μmol/L. In 595 patients, serum soluble transferrin receptor levels were measured. Impaired myocardial reperfusion was defined as lack of ST‐segment resolution ≥50% 60 to 90 minutes after percutaneous coronary intervention. Results ID prevalence varied across these definitions. Impaired reperfusion was present in 12.7% of patients without ID and 41.0% of those with ID defined by transferrin saturation <20% (P<0.001). This association was less pronounced for serum iron ≤13 μmol/L, weaker for guideline criteria, and absent for high (≥1.59 mg/L) soluble transferrin receptor levels or low ferritin. Transferrin saturation <20%, but not ferritin‐based criteria, was associated with poorer clinical course and left ventricular function and higher in‐hospital mortality and remained an independent predictor of impaired reperfusion after adjusting for baseline predictors and anemia. Conclusions ID defined by transferrin saturation <20% is strongly related to impaired ST resolution and predicts a worse in‐hospital outcome in patients with STEMI treated with primary percutaneous coronary intervention. The association of other ID criteria with myocardial reperfusion or with the clinical course is weaker or absent. The potential preventive or therapeutic strategies targeting ID in STEMI warrant further investigation., This study was funded by Instituto de Salud Carlos III, Spain, through the projects AES PI16/00232 and AES PI23/00068 and the research network CIBERCV (CB16/11/00479), both co‐funded by European Regional Development Fund, and by the Sociedad Española de Cardiología y Fundación Española del Corazón (SEC/FEC‐INV‐BAS 23/11).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Efficacy of a cysteine protease inhibitor compared with enalapril in murine heart failure models

  • Aluja, David
  • Delgado Tomás, Sara
  • Ferreira González, Ignacio
  • Barrabés, José A.
  • miro casas, elisabet
  • Ruiz Meana, Marisol
  • Rodriguez-Sinovas, Antonio
  • Benito, Begoña
  • Inserte, Javier
Cardiovascular medicine; Cell biology, Medicina cardiovascular; Biologia cel·lular, Medicina cardiovascular; Biología celular, Cysteine proteases calpains contribute to heart failure (HF), but it remains unknown whether their inhibition provides any benefit compared to standard pharmacological treatment for HF. Here, we characterize the pharmacological properties of NPO-2270 (NPO) as a potent inhibitor of cysteine proteases. Then, we describe that acute administration of NPO in rodent models of transient ischemia at the time of reperfusion reduces myocardial infarction, while its chronic oral administration attenuates adverse remodeling and cardiac dysfunction induced by ischemic and non-ischemic pathological stimuli more effectively than enalapril when given at the same dose. Finally, we provide evidence showing that the effects of NPO correlate with calpain inhibition and the preservation of the T-tubule morphology, due at least in part to reduced cleavage of the calpain substrate junctophilin-2. Together, our data highlight the potential of cysteine protease inhibition with NPO as a therapeutic strategy for the treatment of heart failure., This work was funded by Instituto de Salud Carlos III, Spain, through the projects AES PI20/01681 and AES PI23/00068; and the research network CIBERCV (CB16/11/00479), both cofunded by European Regional Development Fund; Sociedad Española de Cardiología (SEC/FEC-INV-BAS 22/013); Fundació la Marató de TV3 (FLMTV3/202321-30-31) and PERIS STL/484/2023. Long-Sheng Song is supported by the National Institutes of Health of USA.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Implications of Iron Deficiency in STEMI Patients and in a Murine Model of Myocardial Infarction

  • Inserte Igual, Javier
  • Barrabés Riu, José Antonio
  • Aluja Gonzalez, David
  • Bañeras Rius, Jordi
  • Sánchez Sánchez, Ana
  • Mila Pascual, Laia
  • Lidón Corbi, Rosa María
  • De Carvalho Negrao Valente, Filipa Xavier
  • Rafecas Ventosa, Agnès
  • Rodríguez Sinovas, Antonio
  • Benito Villabriga, Begoña
  • Buera Surribas, Irene
  • Ferreira González, Ignacio
  • Beneitez Pastor, David
  • Ruiz Meana, Marisol
  • Miro Casas, Elisabet
  • Rodríguez Palomares, Jose Fernando
  • Sambola Ayala, Antonia
  • Castellote Bellés, Laura
  • Delgado Tomás, Sara
  • Otaegui Irurueta, Imanol
Infarto agudo de miocardio; Sintasa; Deficiencia de hierro, Infart agut de miocardi; Sintasa; Deficiència de ferro, Acute myocardial infarction; Synthase; Iron deficiency, In patients with a first anterior ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention, iron deficiency (ID) was associated with larger infarcts, more extensive microvascular obstruction, and higher frequency of adverse left ventricular remodeling as assessed by cardiac magnetic resonance imaging. In mice, an ID diet reduced the activity of the endothelial nitric oxide synthase/soluble guanylate cyclase/protein kinase G pathway in association with oxidative/nitrosative stress and increased infarct size after transient coronary occlusion. Iron supplementation or administration of an sGC activator before ischemia prevented the effects of the ID diet in mice. Not only iron excess, but also ID, may have deleterious effects in the setting of ischemia and reperfusion., This study was funded by Instituto de Salud Carlos III, Spain, through the project PI16/00232 and the research network CIBERCV (CB16/11/00479), both cofunded by European Regional Development Fund, and by the Sociedad Española de Cardiología (Proyecto de Investigación Traslacional en Cardiología 2016). The authors have reported that they have no relationships relevant to the contents of this paper to disclose.